Symbols

JYNT

The Joint·NASDAQ

--(--)

JYNT fundamentals

JYNT Q4 2025 Earnings

The Joint (JYNT) released its earnings on Mar 12, 2026: revenue was 15.17M (YoY +4.98%), beat estimates; EPS was 0.06 (YoY +133.33%), beat estimates.

Revenue / YoY

15.17M

+4.98%

EPS / YoY

0.06

+133.33%

Report date

Mar 12, 2026

JYNT Earnings Call Summary for Q4,2025

Refranchising Success: 87% of corporate clinics sold, nearing pure-play model with 48 remaining.
Marketing Pivot: Pain-relief messaging boosts SEO, AI search relevance, and early lead growth.
Financial Health: 2025 EBITDA up 13.9%, $11.3M share buybacks. 2026 guidance: EBITDA $12.5-13.5M, 19-21% margin.
Growth Drivers: Flexible pricing plans, national campaigns, and 25% IRR tech investments.
Risk Management: Cautious pricing tests, focusing on 70% of patients in $60-110K income bracket.

Earnings

EPS

Revenue

Revenue & Expenses

JYNT has released its 2025 Q4 earnings report, with revenue of 15.17M, reflecting a YoY change of 3.08%, and net profit of 991.10K, showing a YoY change of 5510.51%. The Sankey diagram below clearly presents JYNT's revenue sources and cost distribution.

Key Indicators

The Joint (JYNT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

The Joint (JYNT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

The Joint (JYNT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

The Joint (JYNT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown